دورية أكاديمية
أعرض في EDS

Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's disease.

التفاصيل البيبلوغرافية
العنوان: Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's disease.
المؤلفون: Charou D; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Rogdakis T; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Latorrata A; Institute of Chemical Biology, National Hellenic Research Foundation, 11635, Athens, Greece., Valcarcel M; Innovative Technologies in Biological Systems SL (INNOPROT), 48160, Derio, Bizkaia, Spain., Papadogiannis V; Hellenic Centre for Marine Research (HCMR), Institute of Marine Biology Biotechnology and Aquaculture (IMBBC), Heraklion, Crete, Greece., Athanasiou C; Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), 69118, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.; Heidelberg Biosciences International Graduate School, Heidelberg University, 69120, Heidelberg, Germany., Tsengenes A; Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), 69118, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.; Heidelberg Biosciences International Graduate School, Heidelberg University, 69120, Heidelberg, Germany., Papadopoulou MA; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Lypitkas D; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Lavigne MD; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Katsila T; Institute of Chemical Biology, National Hellenic Research Foundation, 11635, Athens, Greece., Wade RC; Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), 69118, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.; Center for Molecular Biology (ZMBH), DKFZ-ZMBH Alliance, Heidelberg University, 69120, Heidelberg, Germany.; Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, 69120, Heidelberg, Germany., Cader MZ; Translational Molecular Neuroscience Group, Dorothy Crowfoot Hodgkin Building, Kavli Institute for Nanoscience, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Calogeropoulou T; Institute of Chemical Biology, National Hellenic Research Foundation, 11635, Athens, Greece., Gravanis A; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece., Charalampopoulos I; Department of Pharmacology, Medical School, University of Crete, 71003, Heraklion, Greece. charalampn@uoc.gr.; Foundation for Research and Technology-Hellas (IMBB-FORTH), Institute of Molecular Biology and Biotechnology, 70013, Heraklion, Greece. charalampn@uoc.gr.
المصدر: Stem cell research & therapy [Stem Cell Res Ther] 2024 Jul 06; Vol. 15 (1), pp. 200. Date of Electronic Publication: 2024 Jul 06.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central
مواضيع طبية MeSH: Alzheimer Disease*/drug therapy , Alzheimer Disease*/metabolism , Alzheimer Disease*/pathology , Neurogenesis*/drug effects , Receptor, trkB*/metabolism , Receptor, trkB*/agonists , Receptor, trkB*/genetics , Neural Stem Cells*/drug effects , Neural Stem Cells*/metabolism , Neural Stem Cells*/cytology , Neuroprotective Agents*/pharmacology, Animals ; Humans ; Mice ; Brain-Derived Neurotrophic Factor/metabolism ; Brain-Derived Neurotrophic Factor/genetics ; Cell Differentiation/drug effects ; Cell Proliferation/drug effects ; Amyloid beta-Peptides/metabolism ; Hippocampus/drug effects ; Hippocampus/metabolism
مستخلص: Background: Neural stem cell (NSC) proliferation and differentiation in the mammalian brain decreases to minimal levels postnatally. Nevertheless, neurogenic niches persist in the adult cortex and hippocampus in rodents, primates and humans, with adult NSC differentiation sharing key regulatory mechanisms with development. Adult neurogenesis impairments have been linked to Alzheimer's disease (AD) pathology. Addressing these impairments by using neurotrophic factors is a promising new avenue for therapeutic intervention based on neurogenesis. However, this possibility has been hindered by technical difficulties of using in-vivo models to conduct screens, including working with scarce NSCs in the adult brain and differences between human and mouse models or ethical limitations.
Methods: Here, we use a combination of mouse and human stem cell models for comprehensive in-vitro characterization of a novel neurogenic compound, focusing on the brain-derived neurotrophic factor (BDNF) pathway. The ability of ENT-A011, a steroidal dehydroepiandrosterone derivative, to activate the tyrosine receptor kinase B (TrkB) receptor was tested through western blotting in NIH-3T3 cells and its neurogenic and neuroprotective action were assessed through proliferation, cell death and Amyloid-β (Aβ) toxicity assays in mouse primary adult hippocampal NSCs, mouse embryonic cortical NSCs and neural progenitor cells (NPCs) differentiated from three human induced pluripotent stem cell lines from healthy and AD donors. RNA-seq profiling was used to assess if the compound acts through the same gene network as BDNF in human NPCs.
Results: ENT-A011 was able to increase proliferation of mouse primary adult hippocampal NSCs and embryonic cortical NSCs, in the absence of EGF/FGF, while reducing Aβ-induced cell death, acting selectively through TrkB activation. The compound was able to increase astrocytic gene markers involved in NSC maintenance, protect hippocampal neurons from Αβ toxicity and prevent synapse loss after Aβ treatment. ENT-A011 successfully induces proliferation and prevents cell death after Aβ toxicity in human NPCs, acting through a core gene network shared with BDNF as shown through RNA-seq.
Conclusions: Our work characterizes a novel BDNF mimetic with preferable pharmacological properties and neurogenic and neuroprotective actions in Alzheimer's disease via stem cell-based screening, demonstrating the promise of stem cell systems for short-listing competitive candidates for further testing.
(© 2024. The Author(s).)
References: J Neurosci. 2019 Mar 27;39(13):2441-2458. (PMID: 30700530)
Stem Cell Res. 2011 Jul;7(1):41-53. (PMID: 21530437)
Bioinformatics. 2015 Jan 15;31(2):166-9. (PMID: 25260700)
ACS Chem Neurosci. 2021 Jul 7;12(13):2448-2461. (PMID: 34106682)
J Neurochem. 2005 Jun;93(6):1412-21. (PMID: 15935057)
Front Pharmacol. 2016 Dec 26;7:512. (PMID: 28082899)
Mol Neurobiol. 2019 Jun;56(6):3922-3936. (PMID: 30225776)
Endocrinology. 2015 Jan;156(1):16-23. (PMID: 25330101)
Exp Neurol. 2005 Apr;192(2):348-56. (PMID: 15755552)
Neuron. 2018 Jun 27;98(6):1141-1154.e7. (PMID: 29861287)
Brain Res Mol Brain Res. 2000 Jan 10;75(1):61-9. (PMID: 10648888)
Cell Death Dis. 2013 Nov 21;4:e924. (PMID: 24263098)
Nucleic Acids Res. 2012 May;40(10):4288-97. (PMID: 22287627)
PLoS One. 2011;6(9):e23691. (PMID: 21912641)
Cell Tissue Res. 2011 Oct;346(1):11-26. (PMID: 21935677)
Cell Death Differ. 2020 Mar;27(3):934-948. (PMID: 31591472)
Eur J Neurosci. 2007 Jun;25(12):3513-25. (PMID: 17610571)
PLoS One. 2016 Jun 09;11(6):e0157022. (PMID: 27280887)
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2687-92. (PMID: 20133810)
Transl Psychiatry. 2016 Oct 4;6(10):e907. (PMID: 27701410)
Cell Stem Cell. 2019 Jun 6;24(6):974-982.e3. (PMID: 31130513)
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5599-E5607. (PMID: 28655839)
Neuropharmacology. 2020 Mar 15;165:107919. (PMID: 31877321)
Cell Stem Cell. 2009 Dec 4;5(6):634-45. (PMID: 19951691)
Int J Mol Sci. 2020 Sep 18;21(18):. (PMID: 32962164)
Am J Psychiatry. 2011 Feb;168(2):163-72. (PMID: 21123312)
Cell Res. 2022 Aug;32(8):729-743. (PMID: 35750757)
J Neurosci. 2010 Sep 15;30(37):12252-62. (PMID: 20844121)
Stem Cells Dev. 2006 Jun;15(3):407-21. (PMID: 16846377)
FASEB J. 2011 Oct;25(10):3570-82. (PMID: 21746862)
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16217-22. (PMID: 24043773)
J Comp Neurol. 1965 Jun;124(3):319-35. (PMID: 5861717)
Nat Neurosci. 2002 May;5(5):438-45. (PMID: 11953752)
Mol Neurobiol. 2015;51(3):1271-7. (PMID: 24986007)
Stem Cell Reports. 2021 Apr 13;16(4):681-693. (PMID: 33636114)
Nat Cell Biol. 2019 Sep;21(9):1060-1067. (PMID: 31481793)
Nat Biotechnol. 2019 Aug;37(8):907-915. (PMID: 31375807)
J Neurosci Res. 2010 Aug 1;88(10):2103-17. (PMID: 20209626)
J Neurochem. 2012 Aug;122(4):800-11. (PMID: 22694088)
Nature. 2002 May 2;417(6884):39-44. (PMID: 11986659)
Neurobiol Dis. 2022 Jan;162:105563. (PMID: 34838668)
Front Cell Dev Biol. 2020 Sep 16;8:860. (PMID: 33042988)
Mol Cell Neurosci. 2011 Jan;46(1):108-21. (PMID: 20807572)
Mol Brain. 2017 Jun 1;10(1):19. (PMID: 28569173)
PLoS One. 2014 May 30;9(5):e98586. (PMID: 24879416)
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4475-84. (PMID: 26216953)
Nat Neurosci. 2022 Jun;25(6):805-817. (PMID: 35637371)
Cell. 2021 Mar 4;184(5):1299-1313.e19. (PMID: 33606976)
Neuroscience. 2019 Dec 1;422:21-31. (PMID: 31682957)
Ageing Res Rev. 2021 Nov;71:101447. (PMID: 34403830)
Neuromolecular Med. 2002;1(2):125-35. (PMID: 12025858)
Int J Mol Sci. 2021 Dec 13;22(24):. (PMID: 34948177)
Cell Stem Cell. 2018 Apr 5;22(4):589-599.e5. (PMID: 29625071)
Nature. 2022 Jul;607(7919):527-533. (PMID: 35794479)
PLoS One. 2012;7(10):e46577. (PMID: 23056351)
Neurology. 2016 Feb 23;86(8):702-3. (PMID: 26819454)
Development. 2013 Jan 15;140(2):459-70. (PMID: 23193167)
Neuron. 2010 May 27;66(4):523-35. (PMID: 20510857)
Neural Regen Res. 2022 Dec;17(12):2615-2618. (PMID: 35662190)
Neurobiol Aging. 2006 Jul;27(7):909-17. (PMID: 15979211)
Nature. 1967 Jun 10;214(5093):1098-101. (PMID: 6053066)
J Clin Invest. 2010 May;120(5):1774-85. (PMID: 20407211)
Neurobiol Dis. 2017 Dec;108:307-323. (PMID: 28865749)
Cell Stem Cell. 2022 Dec 1;29(12):1637-1652.e6. (PMID: 36459967)
Neural Regen Res. 2019 May;14(5):817-825. (PMID: 30688267)
Cell Rep. 2020 Jan 7;30(1):215-228.e5. (PMID: 31914388)
J Neurosci. 2007 Jun 20;27(25):6771-80. (PMID: 17581964)
Cell Stem Cell. 2023 Feb 2;30(2):120-136. (PMID: 36736288)
J Neurosci. 1996 Mar 15;16(6):2027-33. (PMID: 8604047)
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7526-31. (PMID: 10377448)
Hippocampus. 2012 Mar;22(3):399-408. (PMID: 21136519)
Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308)
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15570-5. (PMID: 18832146)
J Neurosci. 2002 Nov 15;22(22):9868-76. (PMID: 12427843)
Sci Rep. 2018 Jan 30;8(1):1916. (PMID: 29382944)
Neuropharmacology. 2017 Jul 15;121:140-157. (PMID: 28461162)
Neuron. 2008 Aug 14;59(3):399-412. (PMID: 18701066)
Aging Dis. 2021 Dec 1;12(8):2151-2172. (PMID: 34881092)
Cell Stem Cell. 2009 Sep 4;5(3):320-31. (PMID: 19733543)
Neurosci Lett. 2000 Jul 7;288(1):53-6. (PMID: 10869814)
J Neurosci. 2015 May 13;35(19):7538-51. (PMID: 25972179)
Cell Stem Cell. 2010 May 7;6(5):445-56. (PMID: 20452319)
PeerJ. 2021 May 12;9:e11388. (PMID: 34026357)
Stem Cells. 2012 Jul;30(7):1509-20. (PMID: 22532528)
Dev Neurobiol. 2011 Aug;71(8):680-9. (PMID: 21412988)
Nat Med. 2019 Apr;25(4):554-560. (PMID: 30911133)
Elife. 2018 May 10;7:. (PMID: 29745900)
J Neurochem. 2002 Dec;83(6):1509-24. (PMID: 12472904)
Neurosci Bull. 2014 Aug;30(4):542-56. (PMID: 25082534)
Cell Stem Cell. 2021 Oct 7;28(10):1805-1821.e8. (PMID: 34033742)
Nat Med. 1998 Nov;4(11):1313-7. (PMID: 9809557)
Nature. 2002 Feb 28;415(6875):1030-4. (PMID: 11875571)
Science. 2018 Sep 7;361(6406):. (PMID: 30190379)
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21924-9. (PMID: 19959663)
Stem Cell Res Ther. 2021 Jun 10;12(1):335. (PMID: 34112234)
Cell. 2008 Feb 22;132(4):645-60. (PMID: 18295581)
Eur J Neurosci. 2006 Oct;24(7):1850-6. (PMID: 17040481)
Brain Res. 2009 Mar 25;1262:89-99. (PMID: 19401174)
Nature. 2005 Oct 27;437(7063):1370-5. (PMID: 16251967)
Nat Commun. 2019 Apr 3;10(1):1523. (PMID: 30944313)
Biomedicines. 2022 Mar 06;10(3):. (PMID: 35327415)
FASEB J. 2002 Aug;16(10):1328-30. (PMID: 12154010)
Neurobiol Aging. 2003 Mar-Apr;24(2):273-84. (PMID: 12498961)
J Neurosci. 2009 Jun 24;29(25):7966-77. (PMID: 19553437)
Biochem Biophys Res Commun. 2002 Jun 28;294(5):1087-92. (PMID: 12074588)
Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):a021287. (PMID: 25833845)
Neuropharmacology. 2016 Nov;110(Pt A):343-361. (PMID: 27334657)
Nat Struct Mol Biol. 2022 Dec;29(12):1277-1290. (PMID: 36482253)
Sci Rep. 2016 Jun 06;6:27358. (PMID: 27264956)
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13632-7. (PMID: 14581618)
Cell Signal. 2006 Nov;18(11):1995-2003. (PMID: 16647839)
Neuron. 1991 Nov;7(5):695-702. (PMID: 1742020)
Brain Res. 2014 Jan 13;1542:32-40. (PMID: 24140109)
Arch Neurol. 2000 Jun;57(6):846-51. (PMID: 10867782)
Nature. 2003 Nov 6;426(6962):74-8. (PMID: 14603320)
Nat Protoc. 2012 Oct;7(10):1836-46. (PMID: 22976355)
J Neuroimmunol. 2010 Mar 30;220(1-2):90-8. (PMID: 20176405)
معلومات مُعتمدة: 765704 Horizon 2020; 101099145 HORIZON EUROPE European Innovation Council
فهرسة مساهمة: Keywords: Alzheimer’s disease; BDNF; In-vitro drug testing; Neurogenesis; Stem-cell based screening; TrkB; iPSC
المشرفين على المادة: EC 2.7.10.1 (Receptor, trkB)
0 (Neuroprotective Agents)
0 (Brain-Derived Neurotrophic Factor)
0 (Amyloid beta-Peptides)
تواريخ الأحداث: Date Created: 20240706 Date Completed: 20240706 Latest Revision: 20240718
رمز التحديث: 20240719
مُعرف محوري في PubMed: PMC11227723
DOI: 10.1186/s13287-024-03818-w
PMID: 38971770
قاعدة البيانات: MEDLINE
كن أول من يترك تعليقا!
يجب تسجيل دخولك أولا